The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
A Preliminary Study on the Relationship between Serum Heparan Sulfate and Cancer-Related Cognitive Impairment: The Moderating Role of Oxidative Stress in Patients with Colorectal Cancer
Abstract
Cancer-related cognitive impairment (CRCI) has been frequently reported in colorectal cancer survivors. Heparan sulfate (HS) was gradually considered to be related to cognitive disorders. The effect and potential mechanism of HS on CRCI in colorectal cancer patients were unexplored. In this study, all participants were divided into a cognitive impaired group and a cognitive normal group. The concentrations of oxidative stress factors and HS in serum were detected. Associations among HS, oxidative stress factors and CRCI were evaluated. Participants with cognitive impairment exhibited increased levels of HS, GSH, SOD and MDA, compared to the patients with normal cognitive performance. The independent significant association was found between HS and CRCI after controlling for various covariates. The higher concentrations of HS were related to the decreased cognitive performance among survivors who reported higher levels of GSH (β = 0.080, p = 0.002). Moreover, the nonlinear association between the level of HS and cognitive scores was confirmed using the restricted cubic splines (p < 0.001). These results indicated that the increased concentrations of circulating HS had a nonlinear negative connection with cognitive performance in colorectal cancer survivors, which was moderated by GSH. HS might be a new biomolecule for the identification and management of patients with CRCI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971
How does multiple testing correction work?
Noble, W. S. (2009) · Nature Biotechnology · doi:10.1038/nbt1209-1135 · Cited by 772
Ren, X., Keeney, J. T. R., Miriyala, S., Noel, T., Powell, D. K., Chaiswing, L., Bondada, S., St. Clair, D. K., & Butterfield, D. A. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.12.029 · Cited by 88
Glycan Determinants of Heparin-Tau Interaction
Zhao, J., Huvent, I., Lippens, G., Eliezer, D., Zhang, A., Li, Q., Tessier, P., Linhardt, R. J., Zhang, F., & Wang, C. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.01.024 · Cited by 87
Oxidative Stress and Cognitive Alterations Induced by Cancer Chemotherapy Drugs: A Scoping Review
Cauli, O. (2021) · Antioxidants · doi:10.3390/antiox10071116 · Cited by 60
Circadian control of heparan sulfate levels times phagocytosis of amyloid beta aggregates
Clark, G. T., Yu, Y., Urban, C. A., Fu, G., Wang, C., Zhang, F., Linhardt, R. J., & Hurley, J. M. (2022) · PLOS Genetics · doi:10.1371/journal.pgen.1009994 · Cited by 31
Research works printed but not linked: 46
- Lange, 2019, Cancer-related cognitive impairment: An update on state of the art, detection, and management strategies in cancer survivors, Ann. Oncol., 30, 1925, 10.1093/annonc/mdz410 · DOI · Paper page
- Underwood, 2019, Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: A 1-year longitudinal study, Support. Care Cancer., 27, 3035, 10.1007/s00520-018-4603-5 · DOI
- Janelsins, 2018, Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study, J. Clin. Oncol., 36, 3231, 10.1200/JCO.2018.78.6624 · DOI · Paper page
- Vardy, 2014, Cognitive function and fatigue after diagnosis of colorectal cancer, Ann. Oncol., 25, 2404, 10.1093/annonc/mdu448 · DOI
- Ren, 2019, Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors, Biochim. Biophys. Acta. Mol. Basis. Dis., 1865, 1088, 10.1016/j.bbadis.2019.02.007 · DOI
- Wahdan, 2018, Astaxanthin Ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in Experimental Rat Model: Impact on Oxidative, Inflammatory, and Apoptotic Machineries, Mol. Neurobiol., 55, 5727, 10.1007/s12035-017-0797-7 · DOI · Paper page
- Chaudhry, 2019, Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus, Mol. Neurobiol., 56, 7159, 10.1007/s12035-019-1589-z · DOI
- Williams, 2018, Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy, J. Neuroimmunol., 314, 17, 10.1016/j.jneuroim.2017.10.005 · DOI
- Ganz, 2013, Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?, Brain Behav. Immun., 30, S99, 10.1016/j.bbi.2012.07.015 · DOI
- Mulloy, 2017, Mast cell glycosaminoglycans, Glycoconj. J., 34, 351, 10.1007/s10719-016-9749-0 · DOI
- Szatmári, T., Mundt, F., Kumar-Singh, A., Möbus, L., Ötvös, R., Hjerpe, A., and Dobra, K. (2017). Molecular targets and signaling pathways regulated by nuclear translocation of syndecan-1. BMC Cell Biol., 18. · DOI
- Stewart, 2014, Heparan sulfate in the nucleus and its control of cellular functions, Matrix. Biol., 35, 56, 10.1016/j.matbio.2013.10.009 · DOI
- Gulberti, 2020, The role of heparan sulfate maturation in cancer: A focus on the 3O-sulfation and the enigmatic 3O-sulfotransferases (HS3STs), Semin. Cancer Biol., 62, 68, 10.1016/j.semcancer.2019.10.009 · DOI
- Puangmalai, 2020, Internalization mechanisms of brain-derived tau oligomers from patients with Alzheimer’s disease, progressive supranuclear palsy and dementia with Lewy bodies, Cell Death Dis., 11, 314, 10.1038/s41419-020-2503-3 · DOI
- Ordiales, 2020, Heparan Sulfate Proteoglycans Undergo Differential Expression Alterations in Alzheimer Disease Brains, J. Neuropathol. Exp. Neurol., 79, 474, 10.1093/jnen/nlaa016 · DOI
- Alcalde, 2021, Alterations in the Expression of the Genes Responsible for the Synthesis of Heparan Sulfate in Brains With Alzheimer Disease, J. Neuropathol. Exp. Neurol., 80, 446, 10.1093/jnen/nlab028 · DOI
- Hippensteel, 2019, Circulating heparan sulfate fragments mediate septic cognitive dysfunction, J. Clin. Investig., 129, 1779, 10.1172/JCI124485 · DOI
- Reynolds, 2016, Heparan sulfate proteoglycans mediate Aβ-induced oxidative stress and hypercontractility in cultured vascular smooth muscle cells, Mol. Neurodegener., 11, 9, 10.1186/s13024-016-0073-8 · DOI
- Bigger, 2018, Anatomical changes and pathophysiology of the brain in mucopolysaccharidosis disorders, Mol. Genet. Metab., 125, 322, 10.1016/j.ymgme.2018.08.003 · DOI
- Jacobs, 2007, Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoietic stem cell transplant patients, J. Pain Symptom Manag., 33, 13, 10.1016/j.jpainsymman.2006.06.011 · DOI
- Joly, 2012, French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3, Support. Care Cancer, 20, 3297, 10.1007/s00520-012-1439-2 · DOI
- Cheung, 2013, Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer, Value Health, 16, 1001, 10.1016/j.jval.2013.06.017 · DOI
- Cheung, 2014, Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: Cognitive function (FACT-Cog) in breast cancer patients, J. Clin. Epidemiol., 67, 811, 10.1016/j.jclinepi.2013.12.011 · DOI
- Ruan, 2020, Demographically Corrected Normative Z Scores on the Neuropsychological Test Battery in Cognitively Normal Older Chinese Adults, Dement Geriatr Cogn Disord., 49, 375, 10.1159/000505618 · DOI
- Wong, 2018, Neuropsychological Criteria for Mild Cognitive Impairment in the Framingham Heart Study’s Old-Old, Dement. Geriatr. Cogn. Disord., 46, 253, 10.1159/000493541 · DOI
- Ihle, 2019, Cognitive Reserve Mediates the Relation between Openness to Experience and Smaller Decline in Executive Functioning, Dement. Geriatr. Cogn. Disord., 48, 39, 10.1159/000501822 · DOI
- Duff, 2016, Demographically corrected normative data for the Hopkins Verbal Learning Test-Revised and Brief Visuospatial Memory Test-Revised in an elderly sample, Appl. Neuropsychol. Adult., 23, 179, 10.1080/23279095.2015.1030019 · doi:10.1080/23279095.2015.1030019
- Morimoto, 2021, Clearance of heparan sulfate in the brain prevents neurodegeneration and neurocognitive impairment in MPS II mice, Mol. Ther., 29, 1853, 10.1016/j.ymthe.2021.01.027 · DOI
- Vardy, 2015, Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study, J. Clin. Oncol., 33, 4085, 10.1200/JCO.2015.63.0905 · DOI · Paper page
- Dhillon, 2018, Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy, J. Cancer Surviv., 12, 178, 10.1007/s11764-017-0656-6 · DOI · Paper page
- Vivek, 2022, Cross sectional association between cytomegalovirus seropositivity, inflammation and cognitive impairment in elderly cancer survivors, Cancer Causes Control, 33, 81, 10.1007/s10552-021-01504-3 · DOI
- Chen, 2018, Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer, Breast Cancer Res. Treat., 172, 363, 10.1007/s10549-018-4911-y · DOI
- Wouters, 2016, Neurocognitive function of lymphoma patients after treatment with chemotherapy, Acta Oncol., 55, 1121, 10.1080/0284186X.2016.1189092 · DOI
- Mounier, N.M., Abdel-Maged, A.E., Wahdan, S.A., Gad, A.M., and Azab, S.S. (2020). Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis. Life Sci., 258. · DOI
- Paterson, 2021, Association of renal impairment with cognitive dysfunction in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA), Nephrol. Dial. Transplant., 36, 1492, 10.1093/ndt/gfab182 · DOI
- Stephan, 2019, Subjective Age and Cystatin C Among Older Adults, J. Gerontol. B. Psychol. Sci. Soc. Sci., 74, 382, 10.1093/geronb/gbx124 · DOI
- Wang, 2021, Nutrition Impact Symptom Clusters in Patients With Head and Neck Cancer Receiving Concurrent Chemoradiotherapy, J. Pain Symptom Manage., 62, 277, 10.1016/j.jpainsymman.2020.12.013 · doi:10.1016/j.jpainsymman.2020.12.013
- Cardoso, C.V., de Barros, M.P., Bachi, A.L.L., Bernardi, M.M., Kirsten, T.B., de Fátima Monteiro Martins, M., Rocha, P.R.D., da Silva Rodrigues, P., and Bondan, E.F. (2020). Chemobrain in rats: Behavioral, morphological, oxidative and inflammatory effects of doxorubicin administration. Behav. Brain. Res., 378. · DOI
- Sun, 2019, Superoxide dismutase activity and risk of cognitive decline in older adults: Findings from the Chinese Longitudinal Healthy Longevity Survey, Exp. Gerontol., 118, 72, 10.1016/j.exger.2019.01.010 · DOI
- Lang, 2020, Elevated activity of plasma superoxide dismutase in never-treated first-episode schizophrenia patients: Associated with depressive symptoms, Schizophr. Res., 222, 291, 10.1016/j.schres.2020.05.032 · DOI
- Sugawara, 2002, Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation, J. Neurosci., 22, 209, 10.1523/JNEUROSCI.22-01-00209.2002 · DOI · Paper page
- Gibson, 2020, Treating cancer therapy-related cognitive impairment, Nat. Med., 26, 1174, 10.1038/s41591-020-1014-1 · DOI
- Zhang, 2021, Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: Relevance to Alzheimer’s disease, Acta. Neuropathol. Commun., 9, 84, 10.1186/s40478-021-01182-x · DOI
- Devinsky, 2013, Glia and epilepsy: Excitability and inflammation, Trends Neurosci., 36, 174, 10.1016/j.tins.2012.11.008 · DOI · Paper page
- Okuyama, 2019, Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial, Mol. Ther., 27, 456, 10.1016/j.ymthe.2018.12.005 · DOI
- Zhang, 2021, Collagen/heparan sulfate porous scaffolds loaded with neural stem cells improve neurological function in a rat model of traumatic brain injury, Neural. Regen. Res., 16, 1068, 10.4103/1673-5374.300458 · doi:10.4103/1673-5374.300458
Metadata
- Authors
- Wang, D., Wang, T., Zhu, M., Sun, J., Zhou, Z., Chen, J., & Teng, L.
- Venue
- Current Oncology
- Publisher
- MDPI AG
- Published
- 2022-04-12
- Volume
- 29
- Issue
- 4
- Pages
- 2681-2694
- ISSN
- 1718-7729
- Cited by
- 3
- References
- 6
- Language
- en
- Funders
- National Natural Science Foundation of China (82172583)
- Top Talent Support Program for young and middle-aged people of Wuxi Health Committee (BJ 2020041)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Preliminary Study on the Relationship between Serum Heparan Sulfate and Cancer-Related Cognitive Impairment: The Moderating Role of Oxidative Stress in Patients with Colorectal Cancer. https://app.cochat.ai/papers/10.3390/curroncol29040219
- The paper
- Wang, D., Wang, T., Zhu, M., Sun, J., Zhou, Z., Chen, J., & Teng, L. (2022). A Preliminary Study on the Relationship between Serum Heparan Sulfate and Cancer-Related Cognitive Impairment: The Moderating Role of Oxidative Stress in Patients with Colorectal Cancer. Current Oncology. https://doi.org/10.3390/curroncol29040219
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.